Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without renal dysfunction: a retrospective study.

    Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H.

    Drugs Aging. 2012 Feb 1;29(2):133-42. doi: 10.2165/11598440-000000000-00000.

    PMID:
    22233456
    [PubMed - in process]
    2.

    Spotlight on eldecalcitol in osteoporosis.

    Sanford M, McCormack PL.

    Drugs Aging. 2012 Jan 1;29(1):69-71. doi: 10.2165/11207790-000000000-00000.

    PMID:
    22191725
    [PubMed - in process]
    3.

    Optimal management of cancer treatment-induced bone loss: considerations for elderly patients.

    Tipples K, Robinson A.

    Drugs Aging. 2011 Nov 1;28(11):867-83. doi: 10.2165/11595820-000000000-00000. Review.

    PMID:
    22054228
    [PubMed - indexed for MEDLINE]
    4.

    Optimal Management of Cancer Treatment-Induced Bone Loss: Considerations for Elderly Patients.

    Tipples K, Robinson A.

    Drugs Aging. 2011 Oct 27. [Epub ahead of print]

    PMID:
    22037384
    [PubMed - as supplied by publisher]
    5.

    Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.

    Lukert B, Satram-Hoang S, Wade S, Anthony M, Gao G, Downs R.

    Drugs Aging. 2011 Sep 1;28(9):713-27. doi: 10.2165/11595190-000000000-00000.

    PMID:
    21913737
    [PubMed - indexed for MEDLINE]
    6.

    Understanding patient compliance and persistence with osteoporosis therapy.

    Gold DT.

    Drugs Aging. 2011 Apr 1;28(4):249-55.

    PMID:
    21553400
    [PubMed - indexed for MEDLINE]
    7.

    Denosumab: a review of its use in the treatment of postmenopausal osteoporosis.

    Moen MD, Keam SJ.

    Drugs Aging. 2011 Jan 1;28(1):63-82. doi: 10.2165/11203300-000000000-00000. Review.

    PMID:
    21174488
    [PubMed - indexed for MEDLINE]
    8.

    Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study.

    Mazor KM, Velten S, Andrade SE, Yood RA.

    Drugs Aging. 2010 Dec 1;27(12):999-1008. doi: 10.2165/11584790-000000000-00000.

    PMID:
    21087069
    [PubMed - indexed for MEDLINE]
    9.

    Spotlight on strontium ranelate: in postmenopausal osteoporosis.

    Deeks ED, Dhillon S.

    Drugs Aging. 2010 Sep 1;27(9):771-3. doi: 10.2165/11206440-000000000-00000. Review.

    PMID:
    20809666
    [PubMed - indexed for MEDLINE]
    10.

    Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.

    Archer DF.

    Drugs Aging. 2010 Jul 1;27(7):533-44. doi: 10.2165/11316000-000000000-00000. Review.

    PMID:
    20583848
    [PubMed - indexed for MEDLINE]
    11.

    Secondary prevention of osteoporosis in Australia: analysis of government-dispensed prescription data.

    Hollingworth SA, Gunanti I, Nissen LM, Duncan EL.

    Drugs Aging. 2010 Mar 1;27(3):255-64. doi: 10.2165/11318400-000000000-00000.

    PMID:
    20210370
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk